<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Solanesyl Diphosphate Synthase, Enzyme <span id='am-45' about='obo:IMR_0200483' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-46' property="oboInOwl:id" content="IMR:0200483" datatype="xsd:string"></span><span id='am-47' property="rdfs:label" content="Ubiquinone" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:hasDbXref" content="KEGG:C00399" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>Ubiquinone</span> <br /> Synthetic Pathway, Required Life Cycle Trypanosoma brucei Hua Lai b* Estefan&#195;&#173;a Poropat,c Carlos Pravia,c Malena Landoni,d Alicia S. Couto,d Fernando G. P&#195;&#169;rez Rojo,e Alicia G. Fuchs,c,e <br /> Marta Dubin,f Igal Elingold,f Juan B. Rodr&#195;&#173;guez,g Marcela Ferella,h M&#195;&#179;nica  Esteva,c Esteban J. Bontempi c Julius Luke&#197;&#161;a,b <br /> Biology Centre, Institute Parasitology, Academy Sciences Czech Republic Faculty Sciences, University South Bohemia,b C&#203;&#8225;esk&#195;&#169; Bude&#203;&#8225;jovice, Czech <br /> Republic; Instituto Nacional Parasitolog&#195;&#173;a Dr. M. Fatala Chab&#195;&#169;n, Ministerio Salud, Buenos Aires, Argentinac; CIHIDECAR, Departamento Qu&#195;&#173;mica Org&#195;&#161;nica, <br /> Facultad Ciencias Exactas y Naturales, Universidad Buenos Aires, Buenos Aires, Argentinad; CAECIHS, Universidad Abierta Interamericana, Buenos Aires, Argentinae; <br /> CEFYBO, UBA-CONICET, Facultad Medicina, Buenos Aires, Argentinaf; Departamento Qu&#195;&#173;mica Org&#195;&#161;nica UMYMFOR, Facultad Ciencias Exactas y Naturales, <br /> Universidad Buenos Aires, Buenos Aires, Argentinag; Department Immunology, Genetics Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Swedenh <br />  <br /> Ubiquinone 9 (UQ9), expected product long-chain solanesyl diphosphate synthase Trypanosoma brucei (TbSPPS), central role reoxidation reducing equivalents mitochondrion T. brucei. ablation TbSPPS gene expres- <br /> sion RNA interference increased generation reactive oxygen species reduced cell growth oxygen consumption. addition glycerol culture medium exacerbated phenotype blocking endogenous generation excretion. participation TbSPPS UQ synthesis confirmed growth rescue using UQ 10 isoprenyl subunits <br /> (UQ10). Furthermore, survival infected mice prolonged downregulation TbSPPS addition glycerol drinking water. TbSPPS inhibited 1-[(n-oct-1-ylamino)ethyl] 1,1-bisphosphonic acid, treatment compound lethal cells. findings UQ9 <span id='am-50' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-51' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-56' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-57' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span> pools severely depleted drug exoge- <br /> nous UQ10 able fully rescue growth inhibited parasites strongly suggest TbSPPS UQ synthesis main targets drug. strategies highlight importance TbSPPS T. brucei, justifying efforts vali- <br /> <span id='am-10' about='oboInOwl:date' typeof='owl:Thing'>date</span> new drug target. <br />  <br />  <br />  <br />  <br /> T   hemoflagellate parasite Trypanosoma brucei responsible <br />     sleeping sickness, disease affecting humans vertebrates sub-Saharan Africa. main drugs used                                                                                       far UQ9 detected BSF T. brucei mevalonate, <br />                                                                                       labeled precursor (16, 17). <br />                                                                                           importance UQ parasite&#226;&#8364;&#8482;s metabolism, treatment numerous effects, complicated                         decided study TbSPPS  T. brucei solanesyl diphosphate syn- <br /> administer, poor efficiency increasing incidence drug                     thase), responsible synthesis 9 isoprenyl subunit <br /> resistance reported (1).  new drugs targeting                      chains. Alterations UQ level affect oxygen consump- <br /> essential metabolic pathways urgently needed.                                     tion, reoxidation <span id='am-28' about='obo:IMR_0200521' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-29' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasDbXref" content="KEGG:C00004" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="NADH" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0200521" datatype="xsd:string"></span>NADH</span>, ATP pool. Indirectly,     interested polyprenyl diphosphate synthases,                         mitochondrial membrane potential PCF, produced zymes catalyze elongation isoprenoid chains                       respiratory chain aerobic eukaryotes, condensation isopentenyl <span id='am-23' about='obo:IMR_0200280' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-24' property="rdfs:label" content="Pyrophosphate" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:id" content="IMR:0200280" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasDbXref" content="KEGG:C00013" datatype="xsd:string"></span>pyrophosphate</span>  5-carbon unit,                       decrease. situation different mammalian-infective <br /> C5) allylic prenyl pyrophosphates (2) produce chains                       BSF cells, uniquely generate potential variable length. detection prenylated proteins showed                     ATP-consuming reverse action ATP synthase (18). UQ <br /> short isoprenoid chains, farnesyl geranygeranyl,                      participates regeneration NADH required ATP <br /> deed attached proteins protist (3, 4). Activities key <br />                                                                                       synthesis glycosomes, shortage reduced cofactor enzymes pathway T. brucei,  farnesyl diphos- <br />                                                                                       likely decrease ATP level compartment, phate synthase farnesyl transferase, characterized <br />                                                                                       cytoplasm mitochondrion. <br /> (5, 6, 7).  promising inhibitors <span id='am-5' about='obo:IMR_0200097' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-6' property="rdfs:label" content="Farnesyl diphosphate" datatype="xsd:string"></span><span id='am-7' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:id" content="IMR:0200097" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasDbXref" content="KEGG:C00448" datatype="xsd:string"></span>farnesyl diphosphate</span> <br /> synthase antiparasitic activities tested vitro (8, 9, <br /> 10) vivo (11). <br />                                                                                           Received 6 October 2013 Accepted 20 December 2013 <br />     hand, enzymes synthesizing longer isoprenoid <br />                                                                                           Published ahead print 27 December 2013 <br /> chains far thoroughly studied trypanosoma- <br />                                                                                           Address correspondence Esteban Bontempi, ejbon@yahoo.com, tids (9, 12). product likely incorporated ubiqui- <br />                                                                                           Julius Luke&#197;&#161;, jula@paru.cas.cz. (UQ), central role respiration T. brucei                       * Present address: Hua Lai, Center Parasitic Organisms, State Key Laboratory studied metabolically distinct stages life cycle.                     Biocontrol, School Life Sciences, Sun Yat-Sen University, Guangzhou, bloodstream form (BSF), present vertebrate blood, respires                         People&#226;&#8364;&#8482;s Republic China. <br /> solely trypanosome alternative oxidase (TAO), pro-                          Supplemental material article http://dx.doi.org/10.1128 <br /> cyclic form (PCF), occurs tse-tse fly vector, uses                      /EC.00271-13. <br /> TAO cytochrome c- containing respiratory chain enzymes                                Copyright &#194;&#169; 2014, American Society Microbiology. Rights Reserved. <br />  reviews, references 13 14). UQs different                        doi:10.1128/EC.00271-13 <br /> lengths various parasitic protists (12, 15),  <br />  <br /> 320   ec.asm.org                                          Eukaryotic Cell   p. 320 &#226;&#8364;&#8220;328                                              February 2014 Volume 13 Number 2 <br />                                                                                                                       T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />     Reactive oxygen species (ROS) generated low                 constructs selected described (32, 33). PCF flagel- <br /> rate product respiratory chain, mainly com-                 lates cultured 27&#194;&#176;C SDM79 medium supplied 15 &#226;?&#174;g ml&#226;&#171;&#186;1 <br /> plexes III (19, 20). Having central position respira-            neomycin G418 50 &#226;?&#174;g ml&#226;&#171;&#186;1 hygromycin diluted 106 cells ml&#226;&#171;&#186;1 <br /> tory chain, UQ receives typical cell electrons complexes              day, BSF kept 37&#194;&#176;C HMI-11 medium 2.5 II  present, alternative NADH dehydrogenase.                  &#226;?&#174;g ml&#226;&#171;&#186;1 G418 5% <span id='am-40' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-41' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-42' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-43' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span>CO2</span> diluted 105 cells ml&#226;&#171;&#186;1 day. presence activity T. brucei PCF com-               Phleomycin-resistant transfectants stages (2.5 1.3 &#226;?&#174;g ml&#226;&#171;&#186;1) <br /> plex II rotenone-insensitive alternative NADH dehydroge-                    cloned limiting dilution, RNAi induced adding 1 &#226;?&#174;g <br />                                                                                 ml&#226;&#171;&#186;1 tetracycline medium. Lister 427 PCF (29-13) BSF (90-13) <br /> nase undisputed (13, 14, 21, 22), composition (23, 24) <br />                                                                                 cell lines (34) used inhibition experiments. Cell concentra- activity complex highly unusual (25, 26). <br />                                                                                 tions determined using Neubauer hemocytometer Z2 <br /> Diminishing cellular concentration UQ favor                Coulter Counter. <br /> increase reduced NADH pool parallel formation                         Northern Western blot analyses. Total RNA isolated using <br /> ubisemiquinone, facilitating deviation electrons oxygen               TRIzol (Sigma), 10 &#226;?&#174;g RNA lane loaded 1% formal- consequent mitochondrial ROS formation. lower                     dehyde agarose gel, blotted, linked membrane, hybridized UQ affect function membranes outside                   radiolabeled probe conditions described (35). Total cell <br /> mitochondrion, reduces <span id='am-17' about='obo:IMR_0001362' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-18' property="oboInOwl:hasDbXref" content="CHEBI:25054" datatype="xsd:string"></span><span id='am-19' property="obo:IAO_0000115" content="Organic molecule that is insoluble in water but tends to dissolve in nonpolar organic solvent." datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="lipid" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0001362" datatype="xsd:string"></span>lipid</span> peroxyl radicals radical              lysates separated 12% SDS-PAGE gels, transferred membranes, <br /> scavengers like &#226;?&#163;-tocopheryl  cytochrome b5               probed polyclonal antibodies RNA binding protein 16 <br /> reductase, gene present T. brucei genome,                  (RBP16; kindly provided L. Read) TbSPPS 1:1,000 dilu- <br /> assists extracellular ascorbate stabilization (27).             tions (28). Appropriate secondary antibodies (1:2,000; Sevapharma, <br /> pletion UQ pool T. brucei disrupt redox equilib-              Czech Republic) coupled horseradish peroxidase visualized using <br /> rium, increasing ROS multifaceted action.                             enhanced chemiluminescence kit (Pierce) according manufac- <br />      downregulation mitochondrion-confined                    turer&#226;&#8364;&#8482;s protocol. <br /> TbSPPS (28) triggered metabolic effects life stages               Measurement respiration rate, &#226;&#338;&#172;&#226;&#338;&#191;m, reactive oxygen spe- <br />                                                                                 cies. Oxygen consumption stages measured described  <br /> T. brucei. effects mimicked wild-type cells                                                                                 (35, 36). Changes ROS mitochondrial membrane poten- <br /> TbSPPS bisphosphonate inhibitor 1-[(n-oct-1-ylamino)ethyl]                      tial (&#226;&#338;&#172;&#226;&#338;&#191;m) determined using FACSCalibur FACSAria flow <br /> 1,1-bisphosphonic acid (compound 1) (9). vivo, infected mice                 cytometer instruments (Becton, Dickinson) addition dihydro- <br /> displayed longer survival TbSPPS ablated RNA                     ethidium, TMRE, Mitotracker Deep Red cell suspensions (106 <br /> terferenec (RNAi), confirming importance metabolism                  cells ml&#226;&#171;&#186;1) final concentrations 15 &#226;?&#174;M, 250 nM, 500 nM, respec- parasite.                                                                tively, carbonyl cyanide m-chlorophenyl hydrazine (CCCP) final <br />                                                                                 concentration 20 &#226;?&#174;M used control. total 10,000 events MATERIALS METHODS                                                           acquired region previously established corresponding Materials. Compound 1 prepared previously described (9). Nickel-         parasites. Data analyzed way analysis variance <br /> nitrilotriacetic acid-agarose obtained Qiagen, paraquat, di-       (ANOVA). Significant differences means identified Tukey <br /> hydroethidium, UQ10 provided Sigma. UQ10/&#226;?&#164;-cyclodex-                Dunnett posttests, P value &#226;&#177;&#8226;0.05 adopted mini- <br /> trin  kind gift  &#197;&#160;midovnik) complex 7.5% UQ10 (Bulk            mum criterion significance. Statistical analyses performed using <br /> Medicines <span id='am-33' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-34' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-35' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span>amp</span>; Pharma, Germany) &#226;?&#164;-cyclodextrin (Xi HongChang                GraphPad software. Alterations fluorescence quantified Pharma, China). Tetramethylrhodamine ethyl ester (TMRE) pur-                percentage variation compared untreated parasites used chased Molecular Probes, Mitotracker Deep Red CellTiter-           control. data shown graphs figures expressed Glo reagent obtained Invitrogen Promega, respectively.            means &#226;&#171;&#190; standard deviations independent experiments. <br />     DNA sequencing bioinformatics. entire coding sequence                 vivo infectivity glycerol treatment. Mice food fresh TbSPPS gene PCR amplified genomic DNA (strain 29-13)               water available ad libitum. housing conditions, care, handling, using primers PreBru1 (5=-CCTCGAGATCTATGCACCGTGCTAAT                        euthanasia method approved institution&#226;&#8364;&#8482;s Animal Ethics <br /> ATTATAT-3=) PreBru2 (5=-CCAAGCTTCACAATTCCCGTGTCA                            Committee. determine infectivity trypanosomes depleted GG-3=), introduced BglII HindIII restriction sites, respectively, <br />                                                                                 TbSPPS, groups CD-1 mice (5 animals  infected intra- convenient cloning p2T7-177 RNAi expression vectors.                                                                                 peritoneally 100,000 BSF RNAi cells. drinking water, addition, primer PreBru1 contains XhoI restriction site,                                                                                 group received 1 mg ml&#226;&#171;&#186;1 doxycycline (AppiChem) sweetened 50 <br /> used cloning pZJM RNAi vector. constructs verified <br />                                                                                 mg ml&#226;&#171;&#186;1 sucrose, starting 2 days infection. second group sequencing. Homology searches performed using BLAST                                                                                 received 5% glycerol drinking water, group received <br /> GeneDB, sequences aligned using ClustalX 1.81. molecular <br /> weight isoelectric point obtained ExPASy server (cn-          glycerol doxycycline. control group supplied pure <br /> .expasy.org).                                                                   drinking water. survival recorded twice day. <br />     Determination EC50s. Parasites adjusted initial concen-            High-performance liquid chromatography. calibrate high- <br /> tration 5 &#226;&#171;&#187; 104 BSF 1 &#226;&#171;&#187; 106 PCF ml&#226;&#171;&#186;1 200 &#226;?&#174;l medium loaded          performance liquid chromatography (HPLC) column, following mol- sterile 96 plates. fold serial dilutions compound 1            ecules run: UQ8 extracted hexane Escherichia coli, UQ9 <br /> (boiled ensure complete dissolution sterility) added dupli-      isolated T. brucei, commercially available UQ10. Treated (1 &#226;?&#174;M <br /> cate wells. 3 days, cells wells counted using Neubauer   compound 1) untreated BSF pelleted diluted 1 ml meth- <br /> hemocytometer. assay repeated times. EC50 (effective         anol. internal standard, known UQ10 added. concentration half-maximal growth inhibition) determined using          samples extracted twice 1 ml hexane. extraction fractions CompuSyn software (Combosyn) (29).                                          pooled, dried nitrogen flow, dissolved hexane. Samples <br />     Plasmid constructs, transfections, cloning, RNAi induction,             analyzed HPLC Waters apparatus Supelco C18 column cultivation. size TbSPPS gene (1,080 bp) cloned           0.7 ml min&#226;&#171;&#186;1 flow. mobile phase methanol:hexane, 80:20 (vol/ <br /> pZJM (30) p2T7-177 (31) vectors using XhoI, BglII,               vol), isocratic, loop 5 &#226;?&#174;l, detection 275 nm. HindIII sites included primer sequences. T. brucei PCF 29-13         solvents HPLC grade. UQ9 quantified BSF single marker (SM) cell lines transfected linearized          area curve comparison UQ10 standard. <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                             ec.asm.org 321 <br />  Lai et al. <br />  <br />  <br />  <br />     Measurement ATP content. equal volume CellTiter-Glo <br /> reagent (Promega) added T. brucei, 10-min incubation, <br /> luminescence read Glomax multidetection (Promega). signal directly related (r2 &#226;&#171;&#189; 0.99) cell number  range 30,000 500,000 cells. luminescence produced se- <br /> rum-supplemented HMI-11 medium 2 orders magnitude <br /> lower produced flagellates. <br />  <br /> RESULTS <br /> TbSPPS gene. Trypanosoma cruzi TcSPPS gene, used query, identified single T. brucei gene (Tb09.160.4300), encodes protein calculated molecular mass 39.2 kDa isoelectric point 6.12. alignment TbSPPS TcSPPS revealed proteins presence seven regions <br /> related catalysis binding (37, 38)  Fig. S1 supple- <br /> mental material). TbSPPS gene, identical strains 29-13 TREU927/4, highly conserved T. brucei T. cruzi, 66% 68% identity (83% similarity) <span id='am-61' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-62' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-66' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-68' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>nucleotide</span> <span id='am-69' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-70' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-71' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-72' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-73' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-75' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>amino acid</span> levels, respectively  Fig. S1). Additionally, al- <br /> anine occupies position &#226;&#171;&#186;5 second aspartate- <br /> rich motif  Fig. S1), allowing elongation isoprenoid               FIG 1 Northern Western blot analyses TbSPPS T. brucei RNAi cell <br /> chain longer C15 (39).                                                   lines.   Effects TbSPPS RNAi mRNA protein levels procyclic <br />     Inhibition TbSPPS expression RNAi. assess im-                stage (clone 4). Total RNA protein extracted parental 29-13 <br /> portance protein parasite&#226;&#8364;&#8482;s metabolism, PCF                cells (lane 1), noninduced cells (lane 2), procyclic cells day 6 RNAi <br />                                                                               induction (lane 3). upper panels Northern blot analysis results <br /> BSF cells transfected pZJM p2T7-177 RNAi <br />                                                                               length TbSPPS gene used probe. Ethidium bromide-stained <br /> vectors, respectively, bore length TbSPPS                rRNAs used loading control. lower panels Western blot <br /> gene.  total RNA isolated noninduced                   analysis results showing expression TbSPPS protein cell lines <br /> RNAi-induced PCF clonal cell line analyzed Northern                    RNA panels. target protein detected specific polyclonal <br /> blotting. parental 29-13 cells, TbSPPS abundantly tran-            anti-TbSPPS antibodies. Antibody RBP16 used loading  <br />                                                                               trol. (B) Effects TbSPPS RNAi mRNA protein levels blood- <br /> scribed (band &#226;&#172;&#402;1.9 kb) (Fig. 1A; Fig. S1 supple-           stream stage (clone 6) day 3 RNAi induction. Total protein ex- <br /> mental material),  probably small leakage              tracted parental SM cells (lane 1), noninduced cells (lane 2), T7 promoter, TbSPPS mRNA present non-                  bloodstream cells 3 days RNAi induction (lane 3). TbSPPS RBP16 <br /> induced cells (clone 4). effect likely reflected         detected described panel  <br /> slight growth inhibition noninduced cells compared 29-13 parental cells (Fig. 2A). induction RNAi tet- <br /> racycline, TbSPPS mRNA undetectable 2 days,              chrome c oxidase (complex IV) TAO, respectively, used <br /> concurrent massive appearance double-stranded RNA (Fig.                    discriminate oxygen consumption path- <br /> 1A), slow growth phenotype PCF started day 7               way. RNAi induction, switch pathway (Fig. 2A). Based growth curve, day 6 post-RNAi induction               observed, indicating decreased oxygen  selected subsequent experiments. time point,          sumption rate caused (Fig. 3A; Fig. <br /> levels TbSPPS mRNA corresponding protein                    S3A E supplemental material). hand, undetectable Northern Western blot analyses (Fig. 1A),                 oxygen consumption BSF, rely solely TAO, dropped <br /> confirming high efficiency RNAi.                                       day 3 post-RNAi induction 50%, compared parental <br />     viability BSF cells compromised RNAi             noninduced parasites (Fig. 3B; Fig. S3F). <br /> induction. revealed Western blot analysis, TbSPPS                      Inhibition BSF RNAi cells glycerol compound 1.  <br /> equally abundant parental SM noninduced cells                  der hypoxic anaerobic conditions, glycerol-3-phosphate (clone 6), protein downregulated day 3               <span id='am-11' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-12' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-13' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span>ADP</span> accumulate glycosomes, causing glycerol ki- <br /> post-induction (Fig. 1B). judged protein,             nase operate reverse excrete glycerol (40). leakage. disappearance                  conditions, exogenous glycerol added medium TbSPPS RNAi induction complete, growth inhibi-                   toxic metabolite, diffuse cells, inhibiting tion started day 2 (Fig. 2B).                                      glycerol kinase activity preventing NAD&#226;&#171;&#185; regeneration (41). <br />     Diminished <span id='am-103' about='obo:IMR_0200217' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-104' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-105' property="oboInOwl:hasDbXref" content="KEGG:C00007" datatype="xsd:string"></span><span id='am-106' property="oboInOwl:id" content="IMR:0200217" datatype="xsd:string"></span><span id='am-107' property="rdfs:label" content="O2" datatype="xsd:string"></span>O2</span> consumption. shown Fig. 3, respiration                ablation TbSPPS RNAi decrease function of noninduced PCF cells represented 90%              glycerol-3-phosphate shuttle, addition glycerol parental cell line remained days            enhance ensuing phenotype.  addi- RNAi induction.  day 6, oxygen consump-                  tion 4 mM glycerol HMI-11 medium 5 days tion rate RNAi-induced cells dropped approximately                  just mild inhibitory effect parental BSF cells (3.4 times <br /> 60%, correlation appearance growth phenotype.              slower growth) noninduced TbSPPS BSF cells (5.2 times diminished O2 consumption lasted till day 10 postinduc-              slower growth), RNAi-induced counterparts effect <br /> tion, measurement finished (Fig. 3). Cyanide (KCN)               dramatic (48.7 times slower growth) (Fig. 4A). salicylhydroxamic acid (SHAM), inhibitors cyto-                        examined effect 1-[(n-oct-1-ylamino)ethyl] <br />  <br />  <br /> 322    ec.asm.org                                                                                                                                Eukaryotic Cell <br />                                                                                                                            T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />  <br /> FIG 2 Effects TbSPPS RNAi cell growth procyclic form           FIG 3 Effects TbSPPS RNAi oxygen consumption rate pro- <br /> bloodstream form (B) T. brucei. Cell densities  cells ml&#226;&#171;&#186;1) procyclic <br />                                                                                   cyclic   bloodstream (B) forms cells.   procyclics, relative <br /> forms bloodstream forms measured diluted described                                                                                   contributions alternative pathway TAO cytochrome- <br /> text. total cell numbers calculated plotted logarithmic scale <br />                                                                                   mediated pathway (OXPHOS) measured parental 29-13 cells, nonin- y axis 14 days   6 days (B). Clonal procyclic form                                                                                     duced cells (-), cells 2, 6, 10 days RNAi induction. bloodstream form (B) parasite growth absence presence 1 mg ml&#226;&#171;&#186;1 <br />                                                                                   O2 consumption inhibited KCN (0.1 mM) reflected capacity tetracycline, induces RNAi, indicated graphs. growth data <br />                                                                                   cytochrome-mediated pathway, inhibited SHAM (0.03 parental procyclic (strain 29-13  ) bloodstream (SM [B]) forms                                                                                   mM) represented TAO activity. noninhibited residual oxygen  shown. <br />                                                                                   sumption taken zero. means standard deviation values                                                                                   experiments shown. (B) absence cytochrome-mediated path- <br />                                                                                   way bloodstream-form cells, respiration mediated TAO. Oxygen <br />                                                                                   consumption measured parental SM cells, noninduced cells (-), cells <br /> 1,1-bisphosphonic acid, termed compound 1,                        1 3 days RNAi induction, cells inhibition compound 1 (1 &#226;?&#174;M <br /> TbSPPS bisphosphonate inhibitor (Fig. 4B). addition                  24 h), RNAi cell group supplied UQ10. Statistical significance <br /> compound 1 (1 &#226;?&#174;M), BSF cell (SM) oxygen consumption                               levels compared control group indicated asterisks: *, P &#226;&#172;? 0.05; ***, <br /> dropped 24 h 30% nontreated parasites                    P &#226;&#172;? 0.0005; ****, P &#226;&#172;? 0.00005. <br /> (Fig. 3B; Fig. S3F supplemental material),  causing severe growth defect (Fig. 4C). tested RNAi-induced cells, strong growth inhibition occurred                      cell forms suggested dramatic increase ROS presence concentration (lower EC50                    PCF flagellates likely generated disruption respi- <br /> low]). Cells grew normally 2 days died suddenly              ratory chain, active life cycle stage. <br /> day 3 (Fig. 4C). noted effect                     corroborate result, paraquat, reagent catalyzing ROS <br /> mimicked treating parental BSF simultaneous                  formation (42), added concentrations ranging 0.5 2 <br /> addition compound 1 4 mM glycerol (22.9-fold growth                        &#226;?&#174;M noninduced RNAi-induced PCF day 5.  <br /> inhibition), suggesting minimal active                    hours later, increment ROS production lasted  <br /> zyme sufficient support growth.                                             eral days detected flow cytometry (data shown).     Measurement ROS, mitochondrial membrane potential,                         effect paralleled significant growth inhibition day 8 effects paraquat treatment. Mitotracker TMRE                       observed paraquat-treated RNAi-induced cells compared fluorophores sensitive mitochondrial membrane potential                    equally treated noninduced counterparts (Fig. 5B).  (&#226;&#338;&#172;&#226;&#338;&#191;m) stain functional mitochondria. Flagellates                   ROS boost knockdown cells responsible increased <br /> stages depleted TbSPPS did significant variation                 sensitivity paraquat. potential compared parental cells.                                      Rescue RNAi exogenous UQ vivo infections. <br />     follow possible outcome disruption                   Addition UQ, downstream product SPPS, medium <br /> respiratory  measured generation ROS using                    alleviate effect RNAi-mediated depletion TbSPPS. <br /> dihydroethidium.  PCF cells, ROS increased contin-                  increase hydrophilicity bioavailability, UQ usually <br /> uously, reaching maximum days 6 8 (Fig. 5A).                        provided bound compounds. used complex RNAi-induced BSF did change fluorescence                     UQ10 &#226;?&#164;-cyclodextrin, molecule widely used phar- <br /> addition dihydroethidium, suggesting changes ROS gen-                    maceutical industry encapsulation (43). Cells ablated eration (data shown). different phenotypes                    TbSPPS subjected different concentrations (1, 10, <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                                   ec.asm.org 323 <br />  Lai et al. <br />  <br />  <br />  <br />  <br />                                                                                      FIG 5 Generation reactive oxygen species   paraquat treatment (B) <br />                                                                                      TbSPPS procyclic cells. Experiments performed twice                                                                                      triplicate samples.   Parental 29-13 cells (area black line), noninduced <br />                                                                                      cells (gray area), procyclics 6 days RNAi induction (area gray <br />                                                                                      line) incubated presence 5 mg ml&#226;&#171;&#186;1 dihydroethidium 30 min. <br />                                                                                      fluorescence distributions, measured flow cytometry, plotted                                                                                      frequency histograms. (B) Growth procyclic form noninduced cells (clone <br /> FIG 4 Growth curve bloodstream transfectant cells presence glyc-        4) cells induced RNAi 5 days (clone 4 Ind), incubated 3 additional <br /> erol compound 1.   addition 4 mM glycerol medium           days presence 0.2, 0.5, 1, 2 &#226;?&#174;M paraquat. growth cells inhibitory effect TbSPPS knockdown RNAi induction (&#226;&#171;&#185;, glycerol),            absence paraquat, noninduced RNAi induced, considered mild effect observed SM parental cells (SM, glycerol)   100%. Statistical significance levels comparisons noninduced cells (-, glycerol). cell lines grown absence     groups indicated asterisks: ***, P &#226;&#172;? 0.0005; ****, P &#226;&#172;? 0.00005. <br /> glycerol controls. (B) <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="chemical" datatype="xsd:string"></span>Chemical</span> structure 1-[(n-oct-1-ylamino)ethyl] 1,1- <br /> bisphosphonic acid (compound 1), potent inhibitor enzymatic activity TcSPPS. (C) addition 1 &#226;?&#174;M compound 1 medium lethal RNAi-induced TbSPPS knockdown cells (&#226;&#171;&#185;, Comp1), just            protective effect ascofuranone (45). groups mice, <br /> small effect observed SM parental cells (SM, Comp1) noninduced cells (-, Comp1). cell lines grown absence        composed animals, infected dose <br /> compound 1 controls. experiment repeated times,               100,000 BSF RNAi transfectants treated different sub- <br /> representative curve shown.                                                       stances, survival rate recorded. replications <br />                                                                                      experimental setup similar results,                                                                                      shown (Fig. 6). 4 days average survival 90 &#226;?&#174;M) mentioned compound added                              animals control group supplied plain drinking water, <br /> cultivation medium. growth parental cells (SM)                        survival rate increased significantly 7 7.6 days mice <br /> sidered 100%. noninduced BSF cells, effect                    drinking water containing glycerol doxycycline, respectively. concentrations growth (89 95% growth).                           longest average survival 11.2 days recorded <br /> RNAi-induced parasites (56% growth) marginally affected                         animals supplied drinking water containing sub- addition 1 &#226;?&#174;M UQ&#226;&#8364;&#8220;&#226;?&#164;-cyclodextrin (65% growth),                          stances (Fig. 6). <br /> significant rescue (79% 85% growth) observed                              Metabolic effects compound 1 T. brucei. Compound 1 <br /> presence compounds 10 &#226;?&#174;M 90 &#226;?&#174;M, respectively                         shown potent inhibitor T. cruzi SPPS,  Fig. S2 supplemental material). addition                    EC50 250 nM (9). similarities active site UQ10, oxygen consumption returned normal compared                          enzymatic mechanism type E-polyprenyl diphosphate syn- parental noninduced parasites (Fig. 3B; Fig. S3F).                  thases, hypothesized compound 1 active <br />      tested infection animals transfected para-                  TbSPPS protein.  affected growth sites. humans, ingested glycerol raise serum concentra-                   T. brucei life forms, EC50 2 &#226;?&#174;M BSF compared <br /> tion 20 mM, normal 0.05 mM level (44). T. brucei-                     EC50 50 &#226;?&#174;M PCF. <br /> infected animals, glycerol added drinking water improved                          TbSPPS predicted synthesize isoprenoid chain <br />  <br />  <br /> 324    ec.asm.org                                                                                                                                      Eukaryotic Cell <br />                                                                                                                         T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br />                                                                                     bition 90-13 BSF cell line caused treatment com- <br />                                                                                     pound 1. inhibitor used concentration 10 &#226;?&#174;M, <br />                                                                                     lethal BSF 3 days. eliminate possibility <br />                                                                                     inhibitor getting trapped &#195;&#376;-cyclodextrin, added com- <br />                                                                                     mercial UQ10 medium. spite limited aque- <br />                                                                                     ous solubility bisphosphonate, lethal phenotype                                                                                     fully superseded presence 20 &#226;?&#174;M UQ10, BSF cells <br />                                                                                     grew normal rate (Fig. 7D). <br />  <br />                                                                                     DISCUSSION <br />                                                                                     effort novel chemotherapeutic targets patho- <br />                                                                                     genic trypanosomatids, decided study long chain poly- <br /> FIG 6 Survival mice infected TbSPPS RNAi transfectant cells prolonged addition glycerol doxycycline. Drinking water <br />                                                                                     prenyl diphosphate synthases. Earlier, SPPS T. cruzi char- <br /> available groups mice, consisting individuals,   acterized (12), bisphosphonate inhibitors tested <br /> pure (water) supplemented 1 mg ml&#226;&#171;&#186;1 doxycyline sweetened 50            recombinant enzyme (9). order validate <br /> mg ml&#226;&#171;&#186;1 sucrose, 5% glycerol, doxycycline glycerol. sur-         enzymes putative targets, performed functional anal- <br /> vival mice followed daily basis.                                        ysis corresponding protein T. brucei using RNAi                                                                                     inhibition compound 1. compound shown inhibit <br />                                                                                     SPPS farnesyl diphosphate synthase T. cruzi (9) UQ9, expected effect compound 1 treatment                       obvious candidate. identification TbSPPS depletion UQ pool. BSF parasites treated                   straightforward high sequence similarity T. cruzi inhibitor concentration close EC50, UQ                      homologue. protein detected PCF BSF cells <br /> extracted separated HPLC. anticipated, significant                      downregulation RNAi inhibition TbSPPS <br /> reduction UQ9 pool (90%) observed                        affected growth  <br /> ditions (Fig. 7A), compared extraction standard (UQ10).                           cells, UQ involved respiration, linked     UQ mediates transfer electrons  respi-                  activities. Deficient respiration reflected dimin- <br /> ratory chain glycerol 3- phosphate:dihydroxyacetone-                     ished oxygen consumption, observed PCF <br /> phosphate shuttle, passed oxygen final <span id='am-93' about='obo:IMR_0200224' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-94' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-95' property="oboInOwl:id" content="IMR:0200224" datatype="xsd:string"></span><span id='am-96' property="rdfs:label" content="Acceptor" datatype="xsd:string"></span><span id='am-97' property="oboInOwl:hasDbXref" content="KEGG:C00028" datatype="xsd:string"></span>acceptor</span>.                   BSF RNAi induction inhibition compound 1. shown oxygen consumption cells incubated com-                      Insufficient mitochondrial  glycosomal) NADH reoxidation <br /> pound 1 Fig. 3. increased concentrations compound 1                      reflected lowered total ATP altered generation used, respiration drop 13% BSF                       &#226;&#338;&#172;&#226;&#338;&#191;m. effect addition glycerol RNAi-induced 16% PCF, compared non-treated cells.                       BSF highlighted survival mechanism cells experiencing targeting TbSPPS RNAi, switch KCN-sensi-                       imbalance NADH/NAD&#226;&#171;&#185; ratio glycosomes. fact, tive SHAM-sensitive respiration inhibited parasites                   failure efficiently reoxidate NADH glycerol-3- <br /> Fig. S3). Trypanosomes reoxidize NADH pool res-                       phosphate:dihydroxyacetone-phosphate shuttle bolstered piration. inhibition compound 1, reduced rate                       production glycerol action glycerol-3-phosphate <br /> reoxidation insufficient provide ATP <span id='am-76' about='obo:IMR_0100118' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-77' property="oboInOwl:hasExactSynonym" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasExactSynonym" content="Gly" datatype="xsd:string"></span><span id='am-79' property="rdfs:label" content="Aminoacetic acid" datatype="xsd:string"></span><span id='am-80' property="oboInOwl:hasDbXref" content="KEGG:C00037" datatype="xsd:string"></span><span id='am-81' property="rdfs:label" content="Gly" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasExactSynonym" content="Glycine" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-84' property="oboInOwl:id" content="IMR:0100118" datatype="xsd:string"></span><span id='am-85' property="rdfs:label" content="Glycine" datatype="xsd:string"></span><span id='am-86' property="rdfs:label" content="glycine" datatype="xsd:string"></span><span id='am-87' property="oboInOwl:hasAlternativeId" content="IMR:0200057" datatype="xsd:string"></span>gly</span>-                     dehydrogenase glycerol kinase.  hindering  <br /> colysis. measured ATP pool BSF using lumines-                      let exogenous glycerol seriously affected cell growth. <br /> cent assay. results expressed luminescent arbitrary                         Nitrogen-containing bisphosphonates earlier units (lau) 5 &#226;&#171;&#187; 104 BSF cells. comparison untreated                     effective vitro vivo T. cruzi toxicity cells (1.4 &#226;&#171;&#187; 105 &#226;&#171;&#190; 28000 lau), treatment 2 &#226;?&#174;M compound 1                       host cells (47). experiment compound 1 RNAi- <br /> lowered signal 6.75 &#226;&#171;&#187; 104 lau, represents 51%                        induced T. brucei, concluded TbSPPS inhibited decrease.                                                                           fashion TcSPPS, reflection high similarities     tested &#226;&#338;&#172;&#226;&#338;&#191;m variation. Low concentrations                         respective active sites. fact, compound 1 effi- <br /> compound 1 produced mild increase potential,                     cient RNAi abolishing enzymatic activity TbSPPS, <br /> centrations exceeding respective EC50 caused slight                      leading lethal phenotype. Regarding redox balance, mas- <br /> crease life stages, significant (10 &#226;&#8364;&#8220;20%) PCF                 sive buildup ROS detected PCF following RNAi induc- <br /> (Fig. 7B). Dissipation 80% potential addition               tion, similar lesser effect seen treatment <br /> uncoupler CCCP served negative control. respiratory chain                   compound 1. incremented production ROS major source ROS (46), alterations expected               respiratory chain controlled mechanisms involving <br /> generate ROS. compared single peak                        <span id='am-88' about='obo:IMR_0200435' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-89' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-90' property="rdfs:label" content="Iron" datatype="xsd:string"></span><span id='am-91' property="oboInOwl:hasDbXref" content="KEGG:C00023" datatype="xsd:string"></span><span id='am-92' property="oboInOwl:id" content="IMR:0200435" datatype="xsd:string"></span>iron</span> superoxide dismutases, transform superoxide radicals <br /> untreated cells, PCF incubated compound 1 formed popu-                       oxygen hydrogen peroxide. isoforms lation 25&#226;&#8364;&#8220;35% higher ROS, additional                          enzymes distributed glycosomes, cytosol, mitochon- <br /> population fluorescent particles (Fig. 7C). BSF cells,                dria (48, 49), address lack functional respiratory chain, depleted                      overexpressed TbSPPS knockdowns. conclusion, TbSPPS treated compound 1 generate normal                           RNAi knockdown parasites treated ROS.  similarly PCF, higher concentra-                         compound 1, generation maintenance &#226;&#338;&#172;&#226;&#338;&#191;m <br /> tions inhibitor generated second peak lower ROS                     ROS main cause phenotype triggered tam- <br /> concentration, likely representing dead dying cells.                             pering TbSPPS. <br />      tested UQ10 rescue growth inhi-                          active synthesis isoprenyl chain, UQ pool, <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                               ec.asm.org 325 <br />  Lai et al. <br />  <br />  <br />  <br />                     estimated 0.1 nmol UQ 109 BSF cells (17), dimin- <br />                     ish according half-life   remains undeter- <br />                     mined T. brucei. UQ half-life varies different organisms, <br />                     ranging rat tissues 49 125 h (50), human <br />                     blood 34 h (51). HPLC results BSF inhibi- <br />                     tion 3 days confirmed huge exhaustion pool, suggest- <br />                     ing half-life T. brucei UQ comparable                     organisms. HPLC experiment provided additional data <br />                     UQ9 content T. brucei cells. average value ob- <br />                     tained 1.825 ng/106 cells, equivalent 2.3 nmol/109 cells.                     represents 1.3 million molecules cell, value higher                     reported (17) lower described cells. <br />                     example, hepatocytes, cells 50 times larger volume, <br />                     contain 246 million molecules cell (52). <br />                         Amino-bisphosphonates caused ATP decrease tape- <br />                     worm model (53), molecular mechanism                     described. T. brucei, ATP generation probably affected <br />                     directly decrease TbSPPS. PCF cells obtain bulk                     ATP substrate-level phosphorylation (54, 55) oxidative <br />                     phosphorylation (35). depletion NAD&#226;&#171;&#185;,  <br />                     interference indirectly affect ATP-producing pro- <br />                     cesses. likely happen BSF, metabolize <br />                     glucose glycosomes (56) depend NADH reoxidation                     mitochondria UQ-dependent glycerol-3-phosphate <br />                     shuttle.  significant decrease ATP plausibly caused                     growth phenotype  longer times higher concentrations <br />                     compound 1, lethal outcome. <br />                         factor considered acquisition UQ                     serum, replenish dwindling intracellular pool, <br />                     following RNAi-mediated ablation TbSPPS inhibition <br />                     drug. organisms including humans, UQ defi- <br />                     ciency increases uptake transport exogenous UQ                     mitochondria (57, 58). serum, UQ normally transported <br />                     lipid particles,   low- high-density lipo- <br />                     proteins, taken specific cell receptors,                     described T. brucei (59&#226;&#8364;&#8220;61).                     demonstrated parasite&#226;&#8364;&#8482;s growth affected lipoprotein- <br />                     free serum presence antireceptor antibodies (59, 62). <br />                         complex &#226;?&#164;-cyclodextrin, UQ10 appar- <br />                     ently taken trypanosomes, exogenous UQ rescued <br />                     growth, affected RNAi-mediated  <br />                     regulation specific inhibition TbSPPS. complementa- <br />                     tion effect exogenous UQ inhibited parasites clearly pin- <br />                     points UQ biosynthesis protein farnesylation                     main target compound 1. highlighting importance  <br />  <br />  <br />                     FIG 7 Metabolic effects inhibition compound 1 wild-type para- <br />                     sites.   Measurement UQ pool. HPLC representative runs  <br />                     treated treated bloodstreams shown. positions calibration <br />                     standards indicated arrows. (B) &#226;&#338;&#172;&#226;&#338;&#191;m displayed procyclics <br />                     treated different concentrations compound 1. Statistical analysis <br />                     results representative experiment presented. Asterisks indicate <br />                     significant differences comparison control group (untreated par- <br />                     asites). arrowhead represents position depolarized mem- <br />                     brane control, CCCP. (C) ROS level procyclics treated 72 h 50 <br />                     &#226;?&#174;M compound 1. data means &#226;&#171;&#190; standard deviations                     independent experiments. (D) Rescue parental SM bloodstream <br />                     cells. addition 10 &#226;?&#174;M compound 1 medium lethal                     3 days (SM &#226;&#171;&#185; Comp1). addition 20 &#226;?&#174;M UQ10 fully rescued cell <br />                     growth. Nontreated (SM) cells treated UQ10 (SM &#226;&#171;&#185; UQ10) <br />                     used controls. <br />  <br />  <br />  <br /> 326    ec.asm.org                                                                 Eukaryotic Cell <br />                                                                                                                            T. brucei Solanesyl Diphosphate Synthase <br />  <br />  <br />  <br /> UQ BSF cells, rescue experiments results                      protein farnesyltransferase Trypanosoma brucei. J. Biol. Chem. 275: <br /> accordance earlier report, synvinolin                        21870 &#226;&#8364;&#8220;21876. http://dx.doi.org/10.1074/jbc.M000975200. <br />                                                                                   8.   Garzoni LR, Caldera  Meirelles M, Castro NSL, Docampo R, <br /> (simvastatin) reduced cell growth inhibition                        Meints GA, Oldfield E, Urbina JA. 2004. Selective vitro effects enzyme mevalonate pathway, 3-hydroxy-3-meth-                          farnesyl pyrophosphate synthase inhibitor risedronate Trypanosoma <br /> ylglutaryl coenzyme reductase (62). enzyme responsible                       cruzi. Int. J. Antimicrob. Agents 23:273&#226;&#8364;&#8220;285. http://dx.doi.org/10.1016/j synthesis sterols isoprenoids. addition exog-                    .ijantimicag.2003.07.020. <br /> enous mevalonate low-density lipoprotein particles,                      9.   Szajnman SH, Garc&#195;&#173;a Li&#195;&#177;ares GE, Li ZH, Jiang C, Galizzi M, Bontempi <br />                                                                                        EJ, Ferella M, Moreno SN, Docampo R, Rodriguez JB. 2008. Synthesis <br /> transport final products pathway, com-                       biological evaluation 2-alkylaminoethyl-1,1-bisphosphonic acids <br /> pletely reverted phenotype. Interestingly, growth                       Trypanosoma cruzi Toxoplasma gondii targeting farnesyl <br /> verted efficiently exogenous <span id='am-98' about='obo:IMR_0200486' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-99' property="oboInOwl:hasDbXref" content="KEGG:C00187" datatype="xsd:string"></span><span id='am-100' property="rdfs:label" content="Cholesterol" datatype="xsd:string"></span><span id='am-101' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-102' property="oboInOwl:id" content="IMR:0200486" datatype="xsd:string"></span>cholesterol</span>  indicating                     diphosphate synthase. Bioorg. Med. Chem. 16:3283&#226;&#8364;&#8220;3290. http://dx.doi essential product(s) present low-density lipo-                     .org/10.1016/j.bmc.2007.12.010. <br />                                                                                  10.   Demoro B, Caruso F, Rossi M, Ben&#195;&#173;tez D, Gonzalez M, Cerecetto H, <br /> protein particles, UQ, depleted synvinolin  <br />                                                                                        Paraj&#195;&#179;n-Costa B, Castiglioni J, Galizzi M, Docampo R, Otero L, <br /> hibition (62).                                                                         Gambino D. 2010. Risedronate metal complexes potentially active     experiment transfected parasites RNAi                         Chagas disease. Inorg. Biochem. 104:1252&#226;&#8364;&#8220;1258. http://dx.doi.org/10 <br /> duced vivo showed interference synthesis                           .1016/j.jinorgbio.2010.08.004. <br /> TbSPPS doubled life span infected mice, confirming                11.   Garzoni LR, Waghabi MC, Baptista MM, Castro SL, Meirelles M  <br />                                                                                        Britto NCC, Docampo R, Oldfield E, Urbina JA. 2004. Antiparasitic vitro results. Furthermore, anticipated, excess glycerol                  activity risedronate murine model acute Chagas&#226;&#8364;&#8482; disease. Int. J. substantially prolonged survival infected animals.                      Antimicrob. Agents 23:286 &#226;&#8364;&#8220;290. http://dx.doi.org/10.1016/j.ijantimicag experiments reported TbSPPS main                             .2003.07.019. <br /> target compound 1 blocking biosynthesis                  12.   Ferella M, Montalvetti  Rohloff P, Miranda K, Fang J, Reina S, Kawa- <br /> UQ important metabolic consequences T. brucei life                        mukai M, B&#195;&#186;a J, Nilsson D, Pravia C, Katzin  Cassera MB, Aslund L, <br />                                                                                        Andersson B, Docampo R, Bontempi EJ. 2006. solanesyl-diphosphate <br /> stages.                                                                                synthase localizes glycosomes Trypanosoma cruzi. J. Biol. Chem. 281: <br />                                                                                        39339 &#226;&#8364;&#8220;39348. http://dx.doi.org/10.1074/jbc.M607451200. <br /> ACKNOWLEDGMENTS                                                                  13.   Besteiro S, Barrett MP, Rivi&#195;&#168;re L, Bringaud F. 2005. Energy generation <br />                                                                                        insect stages Trypanosoma brucei: metabolism flux. Trends Para- thank Andrej &#197;&#160;midovnik (National Institute Chemistry, Ljubljana,                 sitol. 21:185&#226;&#8364;&#8220;191. http://dx.doi.org/10.1016/j.pt.2005.02.008. <br /> Slovenia) provision UQ10/&#226;?&#164;-cyclodextrin complex, Claudia          14.   Tielens AGM, van Hellemond JJ. 2009. Surprising variety energy <br /> Nose (Instituto Nacional Parasitolog&#195;&#173;a, Buenos Aires, Argentina)                metabolism Trypanosomatidae. Trends Parasitol. 25:482&#226;&#8364;&#8220; 490. <br /> art work, Philippe Bastin (Institut Pasteur, Paris, France) comments               http://dx.doi.org/10.1016/j.pt.2009.07.007. manuscript, Marcelo Arg&#195;&#188;elles (Universidad Nacional                15.   Ellis JE, Setchell KDR, Kaneshiro ES. 1994. Detection ubiquinone Quilmes, Argentina) help flow cytometry experiments. Laurie               parasitic free-living protozoa, including species devoid mitochon- <br /> K. Read (State University New York, Buffalo, NY) kindly provided                    dria. Mol. Biochem. Parasitol. 65:213&#226;&#8364;&#8220;224. <br />                                                                                  16.   Clarkson AB, Bienen EJ, Pollakis G, Grady RW. 1989. Respiration antibodies.                                                                            bloodstream forms parasite Trypanosoma brucei brucei dependent <br />     work supported FOCANLIS2010, FOCAN-                            plant-like alternative oxidase. J. Biol. Chem. 264:17770 &#226;&#8364;&#8220;17776. <br /> LIS2013, Instituto Nacional Parasitolog&#195;&#173;a Dr. Mario Fatala            17.   L&#195;&#182;w P, Dallner G, Mayor S, Cohen S, Chait BT, Menon AK. 1991. Chab&#195;&#169;n, N.L S. Dr. Carlos G. Malbr&#195;&#161;n E.J.B., Grant Agency                mevalonate pathway bloodstream form Trypanosoma brucei. Czech Republic P305/11/2179, project BIOGLOBE CZ.1.07/2.3.00/                      Identification dolichols containing 11 12 isoprene residues. J. Biol. <br /> 30.0032, AMVIS LH12104, Praemium Academiae award J.L.,                      Chem. 266:19250 &#226;&#8364;&#8220;19257. Fellow Canadian Institute Advanced Research.            18.   Schnaufer  Clark-Walker JD, Steinberg AG, Stuart K. 2005.                                                                                        F1-ATP synthase complex bloodstream stage trypanosomes  <br />                                                                                        usual essential function. EMBO J. 24:4029 &#226;&#8364;&#8220; 4040. http://dx.doi.org <br /> REFERENCES                                                                             /10.1038/sj.emboj.7600862. <br />  1. Legros D, Ollivier G, Gastellu-Etchegorry M, Paquet C, Burri C, Jannin       19.   Sugioka K, Nakano M, Totsune-Nakano H, Minakami H, Tero-Kubota <br />     J, B&#195;&#188;scher P. 2002. Treatment human African trypanosomiasis: present            S, Ikegami Y. 1988. Mechanism O2&#226;&#171;&#186; generation reduction     situation needs research development. Lancet Infect. Dis.              oxidation cycle ubiquinones model mitochondrial electron <br />     2:437&#226;&#8364;&#8220; 440. http://dx.doi.org/10.1016/S1473-3099(02)00321-3.                       transport systems. Biochim. Biophys. Acta 936:377&#226;&#8364;&#8220;385. <br />  2. Ohnuma S, Hirooka K, Tsuruoka N, Yano M, Ohto C, Nakane H,                   20.   Turrens JF, Boveris  1980. Generation superoxide anion     Nishino T. 1998. pathway polyprenyl diphosphate elongates               NADH dehydrogenase bovine heart mitochondria. Biochem. J. 191: <br />     prenyltransferase. Insight common mechanism chain length              421&#226;&#8364;&#8220; 427. <br />     termination prenyltransferases. J. Biol. Chem. 273:26705&#226;&#8364;&#8220;26713.           21.   Morales J, Mogi T, Mineki S, Takashima E, Mineki R, Hirawake H, <br />  3. Yokoyama K, Lin Y, Stuart KD, Gelb MH. 1997. Prenylation proteins               Sakamoto K, Omura S, Kita K. 2009. Novel mitochondrial complex II <br />     Trypanosoma brucei. Mol. Biochem. Parasitol. 87:61&#226;&#8364;&#8220; 69.                         isolated Trypanosoma cruzi composed 12 peptides including  4. Field H, Blench  Croft S, Field MC. 1996. Characterisation protein            heterodimeric Ip subunit. J. Biol. Chem. 284:7255&#226;&#8364;&#8220;7263. http://dx.doi.org <br />     isoprenylation procyclic form Trypanosoma brucei. Mol. Biochem.                 /10.1074/jbc.M806623200. <br />     Parasitol. 82:67&#226;&#8364;&#8220; 80.                                                        22.   Fang J, Beattie DS. 2002. Rotenone-insensitive NADH dehydrogenase  5. Montalvetti  Fernandez  Sanders JM, Ghosh S, Van Brussel E,                    potential source superoxide procyclic Trypanosoma brucei mito- <br />     Oldfield E, Docampo R. 2003. Farnesyl pyrophosphate synthase                 chondria. Mol. Biochem. Parasitol. 123:135&#226;&#8364;&#8220;142. http://dx.doi.org/.10.10 <br />     essential enzyme Trypanosoma brucei. vitro RNA interference           16/S0166-685(02)00139-1. <br />     vivo inhibition studies. J. Biol. Chem. 278:17075&#226;&#8364;&#8220;17083. http://dx.doi.org   23.   Panigrahi AK, Z&#195;&#173;kov&#195;&#161;  Dalley RA, Acestor N, Ogata Y, Anupama  Myler <br />     /10.1074/jbc.M210467200.                                                           PJ, Stuart KD. 2008. Mitochondrial complexes Trypanosoma brucei: novel <br />  6. Yokoyama K, Trobridge P, Buckner FS, Van Voorhis WC, Stuart KD,                    complex unique oxidoreductase complex. Mol. Cell. Proteomics <br />     Gelb MH. 1998. Protein farnesyltransferase Trypanosoma brucei:              7:534 &#226;&#8364;&#8220;545. http://dx.doi.org/10.1074/mco.M700430-MCP200. <br />     heterodimer 61- 65-kDa subunits new target antiparasite      24.   Opperdoes FR, Michels PA. 2008. Complex Trypanosomatidae: does <br />     therapeutics. J. Biol. Chem. 273:26497&#226;&#8364;&#8220;26505.                                      exist? Trends Parasitol. 24:310 &#226;&#8364;&#8220;317. http://dx.doi.org/10.1016/j.pt.2008 <br />  7. Buckner FS, Yokoyama K, Nguyen L, Grewal  Erdjument-Bromage                      .03.013. <br />     H, Tempst P, Strickland CL, Xiao L, Van Voorhis WC, Gelb MH. 2000.           25.   Verner  C&#203;&#8225;erm&#195;&#161;kov&#195;&#161; P, &#197;&#160;kodov&#195;&#161;  Kriegov&#195;&#161; E, Horv&#195;&#161;th  Luke&#197;&#161; J. <br />     Cloning, heterologous expression, distinct substrate specificity            2011. Complex (NADH:ubiquinone oxidoreductase) active  <br />  <br />  <br /> February 2014 Volume 13 Number 2                                                                                                                  ec.asm.org 327 <br />  Lai et al. <br />  <br />  <br />  <br />       non-essential procyclic Trypanosoma brucei. Mol. Biochem. Parasitol.               clinical practical applications. Sports Med. 26:145&#226;&#8364;&#8220;167. http://dx <br />       175:196 &#226;&#8364;&#8220;200. http://dx.doi.org/10.1016/j.molbiopara.2010.11.003.                      .doi.org/10.2165/00007256-199826030-00002. <br /> 26.   Surve S, Heestand M, Panicucci B, Schnaufer  Parsons M. 2012.                  45.   Yabu Y, Minagawa N, Kita K, Nagai K, Honma M, Sakajo S, Koide T, <br />       Enigmatic presence mitochondrial complex Trypanosoma brucei                    Ohta N, Yoshimoto  1998. Oral intraperitoneal treatment       bloodstream forms. Eukaryot. Cell 11:183&#226;&#8364;&#8220;193. http://dx.doi.org/10.1128                Trypanosoma brucei brucei combination ascofuranone glyc- <br />       /EC.05282-11.                                                                          erol mice. Parasitol. Int. 47:131&#226;&#8364;&#8220;137. <br /> 27.   Santos-Oca&#195;&#177;a C, C&#195;&#179;rdoba F, Crane FL, Clarke CF, Navas P. 1998.                   46.   Boveris  Oshino N, Chance B. 1972. cellular production hydro- <br />       Coenzyme Q6 iron reduction responsible extracellular                   gen peroxide. Biochem. J. 128:617&#226;&#8364;&#8220; 630. <br />       ascorbate stabilization plasma membrane Saccharomyces cerevi-          47.   Urbina JA, Moreno B, Vierkotter S, Oldfield E, Payares G, Sanoja C, <br />       siae. J. Biol. Chem. 273:8099 &#226;&#8364;&#8220; 8105.                                                  Bailey BN, Yan W, Scott DA, Moreno SN, Docampo R. 1999. Trypano- <br /> 28.   Lai D-H, Bontempi EJ, Luke&#197;&#161; J. 2012. Trypanosoma brucei solanesyl-                     soma cruzi contains major pyrophosphate stores, growth vitro <br />       diphosphate synthase localizes mitochondrion. Mol. Biochem.                     vivo blocked pyrophosphate analogs. J. Biol. Chem. 274: <br />       Parasitol. 183:189 &#226;&#8364;&#8220;192. http://dx.doi.org/10.1016/j.molbiopara.2012.02                33609 &#226;&#8364;&#8220;33615. <br />       .011.                                                                            48.   Dufernez F, Yernaux C, Gerbod D, No&#195;&#171;l C, Chauvenet M, Wintjens R, <br /> 29.   Chou TC. 2006. Theoretical basis, experimental design,                    Edgcomb VP, Capron M, Opperdoes FR, Viscogliosi E. 2006.       ized simulation synergism antagonism drug combination stud-                  presence iron-containing superoxide dismutase isozymes       ies. Pharmacol. Rev. 58:621&#226;&#8364;&#8220; 681. http://dx.doi.org/10.1124/pr.58.3.10.                trypanosomatidae: characterization, subcellular localization, phylo- <br /> 30.   Wang  Morris JC, Drew  Englund PT. 2000. Inhibition                            genetic origin Trypanosoma brucei. Free Radic. Biol. Med. 40:210 &#226;&#8364;&#8220;225. <br />       Trypanosoma brucei gene expression RNA interference using inte-                  http://dx.doi.org/10.1016/j.freeradbiomed.2005.06.021. <br />       gratable vector opposing T7 promoters. J. Biol. Chem. 275:40174 &#226;&#8364;&#8220;           49.   Wilkinson SR, Prathalingam SR, Taylor MC, Ahmed  Horn <br /> </body></html>